Stock HCG HEALTHCARE GLOBAL ENTERPRISES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials HealthCare Global Enterprises Limited

Equities

HCG

INE075I01017

Healthcare Facilities & Services

Market Closed - NSE India S.E.
Other stock markets
 12:43:54 28/06/2024 BST 		5-day change 1st Jan Change
380 INR +2.30% Intraday chart for HealthCare Global Enterprises Limited -0.34% +3.97%
06-28 HealthCare Global Enterprises to Acquire Vizag Hospital MT
06-28 HealthCare Global Enterprises Limited entered into share purchase agreement to acquire 51% stake in Vizag Hospital and Cancer Research Centre Private Limited for INR 2.1 billion. CI

Valuation

Fiscal Period: Maart 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,342 6,570 23,881 37,519 36,511 52,952 - -
Enterprise Value (EV) 1 24,802 12,483 27,604 44,350 43,069 47,056 61,332 59,651
P/E ratio -78 x -6.15 x -11.2 x 68 x 125 x 98.5 x 58.7 x 36.8 x
Yield - - - - - - - -
Capitalization / Revenue 1.98 x 0.6 x 2.36 x 2.68 x 2.15 x 2.47 x 2.43 x 2.18 x
EV / Revenue 2.53 x 1.14 x 2.72 x 3.17 x 2.54 x 2.47 x 2.81 x 2.46 x
EV / EBITDA 19.8 x 7.81 x 21.8 x 18.6 x 14.4 x 14.3 x 15.8 x 13 x
EV / FCF -27.5 x 55.9 x 32.4 x 29.8 x 36.4 x 64 x 30.4 x 26.5 x
FCF Yield -3.64% 1.79% 3.08% 3.36% 2.75% 1.56% 3.28% 3.78%
Price to Book 3.54 x 1.72 x 3.43 x 4.31 x 4.24 x 5.95 x 5.79 x 5.08 x
Nbr of stocks (in thousands) 87,919 88,666 125,359 139,012 139,116 139,348 - -
Reference price 2 220.0 74.10 190.5 269.9 262.4 380.0 380.0 380.0
Announcement Date 23/05/19 28/07/20 17/06/21 26/05/22 25/05/23 29/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9,787 10,923 10,134 13,978 16,944 19,079 21,788 24,270
EBITDA 1 1,252 1,599 1,266 2,380 2,987 3,296 3,892 4,583
EBIT 1 401 114.2 -326.3 797 1,352 1,552 2,100 2,575
Operating Margin 4.1% 1.05% -3.22% 5.7% 7.98% 8.14% 9.64% 10.61%
Earnings before Tax (EBT) 1 -333.8 -1,193 -2,287 877.7 448.7 677.2 1,185 1,876
Net income 1 -248 -1,067 -1,935 537.3 293.4 481.4 841.9 1,388
Net margin -2.53% -9.77% -19.09% 3.84% 1.73% 2.52% 3.86% 5.72%
EPS 2 -2.820 -12.05 -17.02 3.970 2.100 3.430 6.469 10.33
Free Cash Flow 1 -902.8 223.3 851 1,489 1,184 915 2,015 2,254
FCF margin -9.22% 2.04% 8.4% 10.65% 6.98% 4.77% 9.25% 9.29%
FCF Conversion (EBITDA) - 13.97% 67.22% 62.56% 39.62% 28.07% 51.76% 49.19%
FCF Conversion (Net income) - - - 277.11% 403.37% 229.7% 239.28% 162.4%
Dividend per Share 2 - - - - - - - -
Announcement Date 23/05/19 28/07/20 17/06/21 26/05/22 25/05/23 29/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Maart 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,740 2,980 3,231 3,520 3,581 3,646 4,080 4,200 4,247 4,417 4,607 4,799 4,886 4,961 5,213
EBITDA 1 378.4 393.6 512.3 617.4 618.6 631.5 721.6 746.9 755.1 763.2 743.1 835.2 873 872 -
EBIT 1 -39.9 9.8 134.5 237.2 204.8 220.5 324.9 338.6 347.4 341.2 333 479.6 466.6 458.6 423.6
Operating Margin -1.46% 0.33% 4.16% 6.74% 5.72% 6.05% 7.96% 8.06% 8.18% 7.72% 7.23% 9.99% 9.55% 9.24% 8.13%
Earnings before Tax (EBT) 1 -353.9 -1,044 -89.2 1,419 - - 104.2 100.2 - 131.3 105.2 293 170 216 -
Net income 1 -347.3 -1,022 -95.7 1,031 - 59.9 60.5 73.8 75.4 83.7 76.1 183.8 157.8 147 -
Net margin -12.67% -34.28% -2.96% 29.29% - 1.64% 1.48% 1.76% 1.78% 1.89% 1.65% 3.83% 3.23% 2.96% -
EPS 2 -2.330 -8.140 -0.7600 7.690 -3.550 - 0.4300 - 0.5400 0.6000 0.5400 2.070 1.940 1.425 1.350
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/02/21 17/06/21 12/08/21 11/11/21 10/02/22 26/05/22 10/08/22 10/11/22 09/02/23 25/05/23 10/08/23 - - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Maart 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,460 5,913 3,723 6,830 6,558 5,609 8,380 6,698
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.362 x 3.698 x 2.941 x 2.87 x 2.195 x 1.721 x 2.153 x 1.462 x
Free Cash Flow 1 -903 223 851 1,489 1,184 915 2,015 2,254
ROE (net income / shareholders' equity) -4.67% -24.9% -19.1% 6.86% 3.39% 4.35% 9.05% 12.1%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 62.10 43.00 55.60 62.60 61.90 63.80 65.60 74.80
Cash Flow per Share - - - - - - - -
Capex 1 1,888 1,078 354 712 1,332 2,070 1,750 1,513
Capex / Sales 19.29% 9.87% 3.5% 5.1% 7.86% 10.79% 8.03% 6.23%
Announcement Date 23/05/19 28/07/20 17/06/21 26/05/22 25/05/23 29/05/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for HealthCare Global Enterprises Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
380 INR
Average target price
411.1 INR
Spread / Average Target
+8.18%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
HEALTHCARE GLOBAL ENTERPRISES LIMITED Stock HealthCare Global Enterprises Limited
+3.97% 635M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.69% 84.15B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-25.20% 74.14B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+1.62% 26.92B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-10.46% 17.15B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.68% 16.83B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-0.73% 15.21B
NATERA, INC. Stock Natera, Inc.
+72.88% 13.3B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+76.04% 12.99B
PURE HEALTH HOLDING Stock Pure Health Holding
-25.79% 12.79B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. HCG Stock
  4. Financials HealthCare Global Enterprises Limited